Cancer Protocol I: Remission

Edino Varga builds models that predict how disease will unfold. One Monday morning he finds an anonymous record in a validation table and recognizes it, feature by feature, as his own — stitched together from screenings, device studies and workplace data that were never collected as one life. The forecast attached to it says he is about to be diagnosed with an aggressive lymphoma. It is right.

To survive, Varga enters an experimental cellular therapy and writes his own limits into the consent: what may be taken from him, what may be kept, and what may never be built. The treatment works. But the people behind the program have been recording far more than his disease, and a file called Subject Zero suggests plans for him that reach well beyond remission.